Drug Trial Radar · NCT07654283
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Sep 1, 2026
Primary completion
Nov 11, 2027
Study completion Mar 30, 2029
Sponsor
- Lead sponsor
- AusperBio Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with CHB treated with Nucleos(t)ide Analogue (NAs).
Conditions
- Hepatitis B, Chronic
Interventions
AHB-137Drug
Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with persistent HBsAg < limit of detection (LOD) and HBV DNA < lower limit of quantification (LLOQ)Time frame: 24 Weeks post AHB-137 treatment (Week 48)
Locations
10 sites in 6 countries. Site status is shown where the registry gives one.
Stanford University School of Medicine
Redwood City, California · Not yet recruiting
Institute of Human Virology
Baltimore, Maryland · Not yet recruiting
NYU Langone Health
New York, New York · Not yet recruiting
Texas Liver Institute
San Antonio, Texas · Recruiting
University of Calgary
Calgary, Alberta, Canada · Not yet recruiting
Toronto General Hospital
Toronto, Ontario, Canada · Not yet recruiting
APHP Hôpital Beaujon
Clichy, France · Not yet recruiting
Clinica Mangiagalli
Milan, Milan, Italy · Not yet recruiting
Vall d'Hebron Hospital
Barcelona, Barcelona, Spain · Not yet recruiting
King's College Hospital
London, London, United Kingdom · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.